Logo

Gen9's DNA Design Portal

Apr 30, 2015

Gen9 has launched a new web-based portal, based on Benchling's cloud-based research platform, for designing and assembling synthetic DNA constructs for use in applications such as antibody and protein engineering, pathway building, and genome construction.

Through the portal, users can design upload, and optimize their sequences for parameters such as design for syntesis, codon usage, and cloning strategy. The portal also provides a tool for editing sequence information and offers storage space for customers' sequences. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.